MediWound (MDWD) Total Non-Current Liabilities (2016 - 2025)
MediWound (MDWD) recorded quarterly Total Non-Current Liabilities of $16.9 million in Q4 2025, down 6.1% quarter-over-quarter from $18.0 million in Q3 2025, and up 7.04% on a YoY basis from $15.8 million in Q4 2024.
MediWound (MDWD) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends
MediWound's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $16.9 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 7.04% year-over-year to $16.9 million; the TTM figure through Dec 2025 stood at $16.9 million (up 7.04% YoY), while the FY2025 annual figure was $16.9 million, up 7.04% from the prior year.
- Total Non-Current Liabilities was $16.9 million for Q4 2025 at MediWound, down from $18.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $27.0 million in Q4 2022 to a low of $11.4 million in Q1 2023.
- Historically, Total Non-Current Liabilities has averaged $15.8 million across 5 years, with a median of $15.9 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 98.79% in 2022, then slumped 38.11% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $13.6 million in 2021, then surged by 98.79% to $27.0 million in 2022, then slumped by 38.11% to $16.7 million in 2023, then declined by 5.6% to $15.8 million in 2024, then advanced by 7.04% to $16.9 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $16.9 million (Q4 2025), $18.0 million (Q3 2025), and $17.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 64.76 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | 16.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.92 Mn |
| Sep 30, 2025 | 18.01 Mn |
| Jun 30, 2025 | 17.81 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 15.80 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 16.82 Mn |
| Mar 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 16.74 Mn |
| Sep 30, 2023 | 16.63 Mn |
| Jun 30, 2023 | 11.45 Mn |
| Mar 31, 2023 | 11.43 Mn |
| Dec 31, 2022 | 27.05 Mn |
| Sep 30, 2022 | 17.92 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 14.03 Mn |
| Jun 30, 2021 | 14.43 Mn |
| Mar 31, 2021 | 14.56 Mn |